These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6892880)

  • 1. [Metabolic aspects of parsalmide in the cat (author's transl)].
    Fleischmann L
    Arzneimittelforschung; 1980; 30(2):294-8. PubMed ID: 6892880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro studies on parsalmide / bioavailability and protein binding (author's transl)].
    Fleischmann L; Pedrazzoli A
    Arzneimittelforschung; 1977; 27(6):1199-201. PubMed ID: 20112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetic and metabolic aspects of parsalmide in various animal species and man].
    Fleischmann L
    Boll Chim Farm; 1980 Jul; 119(7):385-90. PubMed ID: 6893933
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biotransformation of tramadol in man and animal (author's transl)].
    Lintz W; Erlaçin S; Frankus E; Uragg H
    Arzneimittelforschung; 1981; 31(11):1932-43. PubMed ID: 7198474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and quantification of glucuro- and sulfoconjugated metabolites in human urine following oral administration of xenobiotic 19-norsteroids.
    Tseng YL; Sun CY; Kuo FH
    Steroids; 2006 Sep; 71(9):817-27. PubMed ID: 16814335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Parsalmide: a new anti-inflammatory agent. VI. Pharmacokinetic and metabolic aspects in man].
    Fleischmann L; Pedrazzoli A
    Boll Chim Farm; 1976 Feb; 115(2):183-94. PubMed ID: 949360
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of human platelet function by parsalmide.
    Fantasia R; Colombi M; Della Volpe A; Pogliani EM
    Arzneimittelforschung; 1982; 32(10):1312-4. PubMed ID: 6897511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolites of N-ethylbenzamide, N,N-diethylbenzamide and related compounds detected in rat urine by NMR spectroscopy.
    Taylor WG; Hall TW; Vedres DD
    Drug Metab Dispos; 1995 Nov; 23(11):1188-94. PubMed ID: 8591717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parsalmide: a new anti-inflammatory agent. V. Pharmacokinetic and metabolic aspects in the rabbit].
    Fleischmann L; Lavezzo A; Colombo L
    Boll Chim Farm; 1976 Feb; 115(2):175-82. PubMed ID: 949359
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro mutagenicity of anti-inflammatory parsalmide analogues PA7, PA10, and PA31 triggered by biotransformation into hydroxy derivatives.
    Cardoso HS; Bicalho B; Genari P; Santagada V; Caliendo G; Perissutti E; Donato JL; De Nucci G
    Eur J Med Chem; 2006 Mar; 41(3):408-16. PubMed ID: 16417948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enantioselectivity in the excretion of glucuronides of carprofen in man, dogs and horses].
    Delatour P; Garnier F; Maire R
    Bull Acad Natl Med; 1996 Oct; 180(7):1565-72. PubMed ID: 9102142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterisation of renal metabolites of gamma-glutamylfelinylglycine in the urine of the domestic cat (Felis catus).
    Hendriks WH; Harding DR; Rutherfurd-Markwick KJ
    Comp Biochem Physiol B Biochem Mol Biol; 2004 Oct; 139(2):245-51. PubMed ID: 15465671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The urinary excretion profile of naltrexone and metabolites in man.
    Cone EJ; Gorodetzky CW; Yeh SY
    Drug Metab Dispos; 1974; 2(6):506-12. PubMed ID: 4156313
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic transformations of the trimethyl - 3,5,5, cyclohexene-2, one-1 (isophorone) (author's transl)].
    Dutertre Catella H; Phu Lich N; Quoc Quan D; Truhaut R
    Toxicol Eur Res; 1978 Jul; 1(4):209-16. PubMed ID: 741480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fate of amezinium in humans and animals.
    Traut M; Kummer H; Brode E
    Arzneimittelforschung; 1981; 31(9a):1616-22. PubMed ID: 7197976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of human metabolites of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel If channel inhibitor, and investigation of the transporter-mediated renal and hepatic excretion of these metabolites.
    Umehara K; Shirai N; Iwatsubo T; Noguchi K; Usui T; Kamimura H
    Drug Metab Dispos; 2009 Aug; 37(8):1646-57. PubMed ID: 19439489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isolation and identification of some metabolites of bromazine from human urine (author's transl)].
    Goenechea S; Eckhardt G; Fahr W
    Arzneimittelforschung; 1980; 30(9):1580-4. PubMed ID: 6109539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of (-)-epicatechin metabolites and their metabolic fate in the rat.
    Okushio K; Suzuki M; Matsumoto N; Nanjo F; Hara Y
    Drug Metab Dispos; 1999 Feb; 27(2):309-16. PubMed ID: 9929521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.